MindX SciencesMindX Sciences
Order

Patents

PatentIssuedPatent ID
MindX One Certificate of Registration07-14-202698381174
Methods for Objective Assessment of Memory, Early Detection of Risk for Alzheimer‘s Disease, Matching Individuals with Treatments, Monitoring Response to Treatments, and New Methods for Use for Drugs.03-10-2026US-12,569,483-B2
Methods for Objective Assessment of Stress, Early Detection of Risk for Stress Disorders, Matching Individuals with Treatments, Monitoring Response to Treatment, and New Methods of Use for Drugs.01-20-2026US-12,529,704-B2
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Australia)09-04-2025AU 2019235923
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Europe)10-30-2024EP 3307910
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Europe)08-27-2024EP 3765630
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Japan)05-20-2024JP 7491847B2
Precision Medicine for Treating and Preventing Suicidality03-21-2023US-11,608,532-B2
Drugs, Pharmacogenomics and Biomarkers for Active Longevity08-06-2022EP 3 433 380 B1
Blood Biomarkers for Suicidality06-29-2021US-11,047,009-B2
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment04-27-2021US-10,991,449-B2
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Israel)Notice of AllowanceIL 277000
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Canada)Notice of AllowanceCA 2988578

A series of other patents are pending in various jurisdictions.